Results 291 to 300 of about 87,366 (344)

Barriers to and Facilitators of Phosphate Control in Children With CKD. [PDF]

open access: yesKidney Int Rep
McAlister L   +14 more
europepmc   +1 more source

De novo design of phospho-tyrosine peptide binders

open access: yes
Bauer MS   +30 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Hyperphosphatemia and phosphate binders

American Journal of Health-System Pharmacy, 2005
The pathophysiology of hyperphosphatemia associated with end-stage renal disease and treatment with phosphate binders are discussed.Phosphorus is an essential element necessary for the normal function of the human body, required for skeletal construction and synthesis of DNA, proteins, and adenosine triphosphate.
Jason J, Schucker, Kristina E, Ward
openaire   +2 more sources

The safety of phosphate binders

Expert Opinion on Drug Safety, 2006
Disturbances of mineral metabolism occur during the early stages of chronic kidney disease. As renal function worsens, excess dietary phosphorus accumulates and blood levels increase, that can be clearly seen when the glomerular filtration rate has fallen below 30 ml/min/1.73 m2.
Jaume, Almirall   +3 more
openaire   +2 more sources

Lanthanum: A Safe Phosphate Binder

Seminars in Dialysis, 2006
ABSTRACTAccumulation of inorganic phosphate due to renal functional impairment contributes to the increased cardiovascular mortality observed in dialysis patients. Phosphate plays a causative role in the development of vascular calcification in renal failure; treatment with calcium‐based phosphate binders and vitamin D can further increase the Ca × PO4
Veerle P, Persy   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy